Go to the list of all blogs
Allana's Avatar
published in Blogs
Nov 14, 2026
TickeronGET DAILY SIGNALS
CVS Health (CVS) vs UnitedHealth Group (UNH): Diverging Paths in Healthcare

CVS Health (CVS) vs UnitedHealth Group (UNH): Diverging Paths in Healthcare

Key Takeaways

  • CVS is navigating a major structural shift, having announced plans to split its retail pharmacy business from its Aetna insurance and Caremark pharmacy benefits operations.
  • UNH has shown more consistent momentum, rebuilding margins after a difficult stretch while raising its full-year earnings outlook in consecutive quarters.
  • Both companies face Medicare policy and regulatory scrutiny, but UNH currently displays steadier trend consistency and clearer earnings visibility.
  • Tickeron AI Verdict: UNH — based on relative momentum, margin recovery, and more stable market positioning, Tickeron's AI would currently favor UnitedHealth Group over CVS Health.
  • For deeper detail on catalysts and intraday movement, explore CVS Major News, CVS Today's Price Move, UNH Major News, and UNH Today's Price Move.
  • To see which strategies are currently outperforming, explore Trending AI Robots.

Introduction

Healthcare remains one of the equity market’s most closely watched sectors, combining steady demand with notable policy and regulatory risks. This comparison looks at two major players: CVS Health and UnitedHealth Group. While both have exposure to managed care, pharmacy services, and health solutions, their models and recent paths have moved in different directions. Investors comparing a diversified healthcare conglomerate with a more insurance-focused franchise may find the differences useful. Reviewing relative performance, growth drivers, and market positioning provides a grounded way to assess where each stands today. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

CVS Overview and Recent Performance

CVS operates across retail pharmacies, the Aetna insurance unit, and the Caremark pharmacy benefits manager. The company has delivered better earnings in recent quarters, with adjusted EPS rising and revenue growth appearing across segments. It has also lifted its full-year earnings outlook, pointing to improved operating results.

That said, investor sentiment has faced pressure from structural questions. In recent weeks, CVS announced plans to separate into two companies, carving out the retail pharmacy chain from its insurance and pharmacy benefits businesses, with the split expected in the first half of 2028. The move caught many by surprise and led to a meaningful share-price drop, as analysts noted the absence of detailed financial projections. Additional factors include ongoing antitrust review of integrated healthcare models, a largely flat Medicare Advantage rate proposal, and a recent $315 million opioid-related settlement. The picture is one of improving fundamentals set against a changing corporate structure and regulatory questions.

UNH Overview and Recent Performance

UNH runs two primary businesses: UnitedHealthcare for insurance and Optum for health services and data. Following a period of higher medical costs and federal scrutiny around Medicare Advantage billing, the company has shown a clear recovery through 2026. Recent quarters have topped estimates, with adjusted EPS rising sharply year over year and the medical care ratio improving as management has deliberately reduced lower-margin membership to support profitability.

UnitedHealth has raised its full-year earnings guidance in back-to-back quarters, which signals better earnings visibility. The stock has outpaced the broader market and posted solid gains since early 2026, though it remains below earlier peaks. Risks remain, including Department of Justice investigations, regulatory focus on its integrated model, and questions about future revenue growth amid planned membership reductions. Still, investors have responded positively to the disciplined approach to margin recovery. From what I see, the trend consistency here stands out when compared with peers.

Head-to-Head Comparison

The companies are pursuing different strategies. CVS is moving toward a simpler structure by separating its vertically integrated operations, which brings near-term execution and regulatory uncertainty but may create value longer term. UNH is staying with its combined insurance-and-services model, relying on Optum’s diversification and careful pricing to maintain margin progress.

On momentum, UNH has delivered greater trend consistency and stronger relative performance through 2026, while CVS has experienced more volatility around restructuring news. Risk profiles differ as well: CVS contends with antitrust scrutiny and the execution demands of a large separation, whereas UNH faces DOJ inquiries and the challenge of generating growth while intentionally trimming membership. Both remain exposed to Medicare policy changes, yet UNH’s clearer earnings path and repeated guidance increases currently give it an edge in market perception. I’m watching this closely as the data evolves.

Tickeron AI Verdict

Considering factors such as trend consistency, stability, catalysts, and relative positioning, Tickeron’s AI currently leans toward UNH. The stock’s steadier momentum, improving medical cost ratio, and repeated upward guidance revisions point to a more durable near-term trend than CVS, which is dealing with the uncertainty of a major corporate split. This remains a probabilistic view based on current information rather than a firm prediction, and conditions can change rapidly.

Using AI Tools for Ongoing Research

In my own analysis, I frequently review Tickeron’s AI Trading Bots to understand which strategies are showing strength in the current environment. The platform’s library covers a wide range of styles and timeframes, and the curated Trending AI Robots section offers a practical way to compare historical performance and see where momentum is concentrated right now. This helps put individual stock trends into broader context without replacing careful fundamental review.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: UNH, CVS

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


UNH sees its Stochastic Oscillator ascending out of oversold territory

On November 10, 2026, the Stochastic Oscillator for UNH moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 48 instances where the indicator left the oversold zone. In 30 of the 48 cases the stock moved higher in the following days. This puts the odds of a move higher at over 62%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 13, 2026. You may want to consider a long position or call options on UNH as a result. In 47 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 55%.

UNH moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for UNH crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.

Following a +1.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where UNH advanced for three days, in 186 of 330 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.

The Aroon Indicator entered an Uptrend today. In 102 of 244 cases where UNH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 42%.

Bearish Trend Analysis

The 10-day RSI Indicator for UNH moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In 20 of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at 57%.

The Moving Average Convergence Divergence Histogram (MACD) for UNH turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 25 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 54%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UNH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.

UNH broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. UNH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 58 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.594) is normal, around the industry mean (3.520). P/E Ratio (25.266) is within average values for comparable stocks, (126.353). Projected Growth (PEG Ratio) (1.025) is also within normal values, averaging (0.786). UNH has a moderately high Dividend Yield (0.024) as compared to the industry average of (0.009). P/S Ratio (0.757) is also within normal values, averaging (0.569).

The Tickeron Profit vs. Risk Rating rating for this company is 95 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UNH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

Notable companies

The most notable companies in this group are Unitedhealth Group (NYSE:UNH), CVS HEALTH Corp (NYSE:CVS), Elevance Health (NYSE:ELV), Cigna Group (The) (NYSE:CI), Humana (NYSE:HUM), Centene Corp (NYSE:CNC).

Industry description

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

Market Cap

The average market capitalization across the Managed Health Care Industry is 67.69B. The market cap for tickers in the group ranges from 335.99K to 353.79B. UNH holds the highest valuation in this group at 353.79B. The lowest valued company is IHGP at 335.99K.

High and low price notable news

The average weekly price growth across all stocks in the Managed Health Care Industry was 2%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 16%. CVS experienced the highest price growth at 7%, while MOH experienced the biggest fall at 0%.

Volume

The average weekly volume growth across all stocks in the Managed Health Care Industry was -43%. For the same stocks of the Industry, the average monthly volume growth was -27% and the average quarterly volume growth was -48%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 43
Price Growth Rating: 37
SMR Rating: 72
Profit Risk Rating: 83
Seasonality Score: -6 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of hospital and medical service plans

Industry ManagedHealthCare

Industry
Managed Health Care
Address
1 Health Drive
Phone
+1 800 328-5979
Employees
390000
Web
https://www.unitedhealthgroup.com
Interact to see
Advertisement
The central price target used here is $400 , roughly 35% above Alphabet's latest verified closing price of $295.77 (November 13, 2026). This target is the arithmetic mean of verified analyst price targets reviewed, not a single analyst's forecast; independent data providers report comparable consensus averages in the high-$390s to low-$400s.
Upcoming catalysts: Integration of advertising into AI Overviews and Gemini conversations, the scaling of Gemini 3 and newer models across Search and Cloud, and the commercial ramp of the $32 billion Wiz cloud-security acquisition could all shape sentiment into 2026. Strategic positioning: Alphabet's vertically integrated artificial intelligence (AI) stack — from custom TPU (Tensor Processing Unit) chips to the Gemini models to Google Cloud — supports a durable, cost-advantaged position in the AI build-out.
The TETH exchange-traded fund (ETF) is the 21Shares Ethereum Staking ETF, a spot Ethereum fund listed on Cboe BZX, and it does not carry conventional analyst price targets. The $14 objective used here is a technical milestone discussed in public market commentary — roughly the zone where Ethereum could begin confirming a recovery — not an analyst consensus.
The central target of $6.70 is the arithmetic mean of seven recent, individually verified analyst price targets, rounded from $6.67. At a latest price near $3.70, reaching $6.70 would require roughly 81% upside — a very large move.
EUO is a leveraged inverse currency fund targeting -2x the daily performance of the euro versus the U.S. dollar, while XXX is a passive asset-allocation fund blending roughly 75% S&P 500 equities with 25% XRP exposure. The two funds are structurally unrelated: EUO is a tactical hedging and trading tool, whereas XXX is a diversified, long-biased growth vehicle.
CVS Health (CVS) vs UnitedHealth Group (UNH): Diverging Paths in Healthcare